methylprednisolone has been researched along with abiraterone acetate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bosch, B; Chapas-Reed, J; Dreicer, R; Given, R; Higano, CS; Levin, R; Nemeth, P; Stein, CA | 1 |
| Crespo, J; Lainez-Nuez, A; Noguerado-Mellado, B; Rojas-Pérez-Ezquerra, P; Tejero-Alcalde, M; Tornero, P | 1 |
1 trial(s) available for methylprednisolone and abiraterone acetate
| Article | Year |
|---|---|
Randomized phase 2 therapeutic equivalence study of abiraterone acetate fine particle formulation vs. originator abiraterone acetate in patients with metastatic castration-resistant prostate cancer: The STAAR study.
Topics: Abiraterone Acetate; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Gastrointestinal Diseases; Humans; Male; Methylprednisolone; Middle Aged; Neoplasm Metastasis; Particle Size; Prednisone; Prostatic Neoplasms, Castration-Resistant; Therapeutic Equivalency | 2018 |
1 other study(ies) available for methylprednisolone and abiraterone acetate
| Article | Year |
|---|---|
Severe Delayed Hypersensitivity Reaction to Abiraterone Acetate.
Topics: Abiraterone Acetate; Administration, Oral; Allergens; Antineoplastic Agents; Drug Hypersensitivity; Exanthema; Humans; Hypersensitivity, Delayed; Immunization; Male; Methylprednisolone; Middle Aged; Nausea; Prostatic Neoplasms; Vomiting | 2021 |